(NASDAQ:BCDA), SUNNYVALE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — BioCardia(R), Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the three and nine months ended September 30, 2025 by conference call on Wednesday, […]
BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025 GlobeNewswire November 06, 2025 SUNNYVALE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — BioCardia(R), Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and
WASHINGTON, D.C., Nov. 05, 2025 (GLOBE NEWSWIRE) — Download broadcast-quality video of Hutchings' testimony [here]. On Wednesday, Mike Hutchings, Chief Executive Officer of the Houston-based organization Combined Arms, testified before the U.S. Senate Committee on Veterans' Affairs (SVAC) during a hearing on how technology that connects veterans with veteran-serving organizations helps close gaps in support
(NYSE:AGL), NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public. SO WHAT: If
AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 06, 2025 NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on
Veteran-Serving Tech Nonprofit Testifies Before U.S. Senate Veterans' Affairs Committee Combined Arms CEO Mike Hutchings Highlights Technology, Data, and Local Partnerships as Keys to Closing the “Delivery Divide” for Veterans GlobeNewswire November 06, 2025 WASHINGTON, D.C., Nov. 05, 2025 (GLOBE NEWSWIRE) — Download broadcast-quality video of Hutchings' testimony [here]. On Wednesday, Mike Hutchings, Chief Executive
(NASDAQ:FTNT), NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fortinet, Inc. (NASDAQ: FTNT) between November 8, 2024 and August 6, 2025, both dates inclusive (the “Class Period”), of the important November 21, 2025 lead plaintiff deadline. SO WHAT: If
FTNT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Fortinet, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FTNT GlobeNewswire November 06, 2025 NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock
(NYSE:FCX), NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Freeport-McMoRan Inc. (NYSE: FCX) resulting from allegations that Freeport may have issued materially misleading business information to the investing public. SO WHAT: If you
FCX Investor News: If You Have Suffered Losses in Freeport-McMoRan Inc. (NYSE: FCX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 06, 2025 NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on